Saturday, 24 July 2021

RAKSHIT DRUGS PVT LTD WALK IN INTERVIEW ON 26 th, JULY, 2021 @ VIZAG



ABOUT COMPANY :

Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global markets.

Thanks to its sound base of customers worldwide, Rakshit has established itself as the largest producer of Sildenafil Citrate and leading manufacturer of several other products. Focusing on its activities in R&D as well as building up newer facilities/ capacities to catch up with increasing demand year after year.

Rakshit group has 4 cGMP compliance Manufacturing Facilities spread over Andhra Pradesh and Telangana states of India. Supplying its products to all over the globe from Unites States, Europe, Japan, Asia and to Latin America.

Rakshit facilities are approved by the reputed regulatory authorities like, USFDA, Japan PMDA, Korea-MFDS, CDSCO-India. Rakshit facilities also has certifications WHO-HMP, Europe-WC (Written Confirmation) and other certification like ISO 9001-2008.

Rakshit has approved CEP’s for its key products like Sildenafil Citrate, Pantoprazole Sodium and also many CEP filings are in progress.

Rakshit consider people its most important asset, It is a Knowledge driven company with dedicated professionals at the helm handling operations in Research & Development, Production, Quality Assurance, Marketing, Supply Chain and Finance.


VACANCY DETAILS :

Dear all

Greetings from Rakshit drugs.....!

We r looking for below positions:

Engineering :

Qualification : Diploma / B. Tech
Exp : 12 to 15
Position : Manager

ITD:

Qualification : B. Sc / B. Com computers
Exp : 10 to 15 years
Position : Manager

Intrested candidates can attend to interview on Monday (i.e 26.07.2021) after 02:00 PM with relevant documents.

For more information plz contact to below number:

Ashok -HR : +91-7337552322

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

No comments:

Post a Comment